Therefore, we propose that the pathogenic mechanism underlying CED involves the acceleration of osteoclastogenesis and bone resorption by TGF-β1 through Rho GTPase-mediated cell migration and cytoskeletal remodeling, resulting in accelerated bone turnover, decreased bone density and osteoporosis. This evidence concerns the gene TGFB1 and cranioectodermal dysplasia.